Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online July 23, 2008
Diabetes 57:3090-3098, 2008
DOI: 10.2337/db08-0564
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db08-0564v1
57/11/3090    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Dasu, M. R.
Right arrow Articles by Jialal, I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dasu, M. R.
Right arrow Articles by Jialal, I.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

High Glucose Induces Toll-Like Receptor Expression in Human Monocytes

Mechanism of Activation

Mohan R. Dasu1, Sridevi Devaraj1, Ling Zhao2, Daniel H. Hwang2, and Ishwarlal Jialal1

1 Laboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, Sacramento, California
2 U.S. Department of Agriculture/Agricultural Research Service Western Human Nutrition Research Center and University of California, Davis, California

Corresponding author: Ishwarlal Jialal, ishwarlal.jialal{at}ucdmc.ucdavis.edu

OBJECTIVE—Hyperglycemia-induced inflammation is central in diabetes complications, and monocytes are important in orchestrating these effects. Toll-like receptors (TLRs) play a key role in innate immune responses and inflammation. However, there is a paucity of data examining the expression and activity of TLRs in hyperglycemic conditions. Thus, in the present study, we examined TLR2 and TLR4 mRNA and protein expression and mechanism of their induction in monocytic cells under high-glucose conditions.

RESEARCH DESIGN AND METHODS—High glucose (15 mmol/l) significantly induced TLR2 and TLR4 expression in THP-1 cells in a time- and dose-dependent manner (P < 0.05). High glucose increased TLR expression, myeloid differentiation factor 88, interleukin-1 receptor–associated kinase-1, and nuclear factor-{kappa}B (NF-{kappa}B) p65-dependent activation in THP-1 cells. THP-1 cell data were further confirmed using freshly isolated monocytes from healthy human volunteers (n = 10).

RESULTS—Pharmacological inhibition of protein kinase C (PKC) activity and NADPH oxidase significantly decreased TLR2 and TLR4 mRNA and protein (P < 0.05). Knocking down both TLR2 and TLR4 in the cells resulted in a 76% (P < 0.05) decrease in high-glucose–induced NF-{kappa}B activity, suggesting an additive effect. Furthermore, PKC-{alpha} knockdown decreased TLR2 by 61% (P < 0.05), whereas inhibition of PKC-{delta} decreased TLR4 under high glucose by 63% (P < 0.05). Small inhibitory RNA to p47Phox in THP-1 cells abrogated high-glucose–induced TLR2 and TLR4 expression. Additional studies revealed that PKC-{alpha}, PKC-{delta}, and p47Phox knockdown significantly abrogated high-glucose–induced NF-{kappa}B activation and inflammatory cytokine secretion.

CONCLUSIONS—Collectively, these data suggest that high glucose induces TLR2 and -4 expression via PKC-{alpha} and PKC-{delta}, respectively, by stimulating NADPH oxidase in human monocytes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.